scholarly journals Spectrum Analysis of Common Inherited Metabolic Diseases in Chinese Patients Screened and Diagnosed by Tandem Mass Spectrometry

2014 ◽  
Vol 29 (2) ◽  
pp. 162-168 ◽  
Author(s):  
Lianshu Han ◽  
Feng Han ◽  
Jun Ye ◽  
Wenjuan Qiu ◽  
Huiwen Zhang ◽  
...  
Author(s):  
G. V. Baydakova ◽  
T. A. Ivanova ◽  
E. Yu. Zakharova ◽  
O. S. Kokorina

This paper reviews the clinical applications of tandem mass spectrometry in diagnosis and screening for inherited metabolic diseases. The broad-spectrum of diseases covered, specificity, ease of sample preparation, and high throughput provided by the MS/MS technology has led to the development of multi-disorder newborn screening programs in many countries for amino acid disorders, organic acidurias, and fatty acid oxidation defects. The application of MS/MS in selective screening has revolutionized the field and made a major impact on the detection of certain disease classes such as the fatty acid oxidation defects. New specific and rapid tandem mass spectrometry (MS/MS) and high performance liquid chromatography–MS/MS methods are supplementing or replacing some of the classical gas chromatography– MS/MS methods for a multitude of metabolites and disorders. In the near future, we should expect the emergence of new promising methods for diagnosing not only individual nosologic forms, but also entire groups of inherited metabolic diseases.


2020 ◽  
Author(s):  
Zixuan Zhao ◽  
Chi Chen ◽  
Xueshan Sun ◽  
Duo ZHOU ◽  
Xinwen Huang ◽  
...  

Abstract BackgroundFew studies in China have focused on economic evaluation of newborn screening(NBS) for inherited metabolic diseases (IMDs) by tandem mass spectrometry (MS/MS). This study assessed the total costs, benefits, benefit-cost ratio(BCR), cost-utility ratio(CUR) and incremental cost-utility ratio(ICUR) of NBS using MS/MS compared to non-screening group for the first time.MethodsThis study was conducted as a retrospective piece. Newborns who underwent MS/MS screening for IMDs from 2009 to 2018 were included. All records were extracted from a screening management system in NBS Center of Zhejiang province. All costs, including indirect cost, were discounted at a rate of 5% for the whole life-time. The putative benefit of clinical outcomes related to early-diagnosis through screening was assumed as improvements in quality of life and potential life expectancy in screening group.ResultsOf the 3,040,815 newborns screened, 26,297(0.86%) newborns were suspected positive after first-round screening and called back to take another MS/MS screening. 25,670(97.62%) of them followed the latter procedures and finally 735(2.86%) cases were diagnosed through gene sequence analysis. The most frequent cause of IMD was amino acid diseases(n=276), in most cases fatty acid oxidation disorders (n=248), followed by organic acidemias (n=211). The difference of QALYs ranged from 0.78-15.4. The CUR was CNY¥86,155.80/QALY in screening group and CNY¥303,9517.32/QALY in non-screening group. The ICUR was CNY¥-795,686.47/QALY, and the BCR was 1:8.11.ConclusionsNBS using MS/MS can be considered as cost-effective. Nationwide promotion of NBS using MS/MS deserves priority consideration and sufficient publicity.


2020 ◽  
Vol 52 (01) ◽  
pp. 37-38
Author(s):  
Lyazzat Syrlybayeva

BACKGROUND According to the results of the researches common indexes of the prevalence of inherited metabolic diseases (IMD) varies from 1 to 800 on 1 to 2500 alive newborns. IMD are taking one of the first places among children pathology, early children death (40%) and disability[1]. According to systematic review of the 43 forms of the inborn errors of metabolism are related to unexpected death of newborns. For IMD it is common to have a wide spectrum of the unusual clinical manifestation, often they are not diagnosed, while well timed diagnoses and proper treatment are able to prevent severe systematic lesions, which lead to death and disability[2]. For that reason one of the most significant problems of the modern pediatrics is to early diagnosis of IMD. The only way to diagnosis of orphan metabolic diseases is the tandem mass spectrometry (TMS) [3]. AIM Scientifically substantiate the need for implementation of selective screening IMD of children using TMS method in Republic of Kazakhstan (RK) for early diagnosis, therapy of the inherited metabolic diseases, to reduce disability and death rate. MATERIALS AND METHODS Material of the research – dry blood spots, taken using standard methodology on filtered DBS papers, which are used in RK in the program of neonatal screening (for retrospective research – archived samples of the dry blood spots of the children dead during first year of life). Method of the research is tandem mass spectometry (QSight Perkin Elmer). RESULTS Analysis of the archived dry blood spot samples showed metabolic deviations in 20.4% of the cases. The detected changes are related to amino acids metabolic disorders, defects of -oxidation of the fat acids, decrease activity of the glucocerebrosidase (Gaucher’s disease) and sphingomyelinase (Nimman – Pick disease). Results of the selective screening have shown metabolic disorders in 5% of the cases (defects of -oxidation of the fat acids, aminoacidopathy, organic aciduria). CONCLUSIONS The preliminary results of the using TMS for the diagnosis of IMD have shown the need for implementation of selective screening IMD using TMS, which is able to conduct diagnosis of 75 metabolites of 49 IMD in single blood spot, which were not detected in RK previously. Taking into the consideration economic expenses of the government, related to the costs of the systematic treatment, medical service, life expectancy and lifelong support of the disabled children with IMD, early detection of orphan metabolic diseases is the vital condition of the decrease of newborn and children death rate, sickness rate and disability. This research study was carried out as a part of a scientific project funded by West Kazakhstan Marat Ospanov Medical University.


Sign in / Sign up

Export Citation Format

Share Document